US HB2855 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on May 20 2019 - 25% progression, died in committee
Action: 2019-05-21 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 20 2019 - 25% progression, died in committee
Action: 2019-05-21 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Provides for approval of the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides.
Title
To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.
Sponsors
| Rep. Steve King [R-IA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-05-21 | House | Referred to the Subcommittee on Health. |
| 2019-05-20 | House | Referred to the House Committee on Energy and Commerce. |
| 2019-05-20 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/2855/all-info |
| Text | https://www.congress.gov/116/bills/hr2855/BILLS-116hr2855ih.pdf |
